Home › Advaxis's Listeria-based Lm-LLO Immunotherapy Featured in Nature Biotechnology
 

Keywords :   


Advaxis's Listeria-based Lm-LLO Immunotherapy Featured in Nature Biotechnology

2014-12-11 14:21:39| Biotech - Topix.net

Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, announced today that its Lm -LLO immunotherapy technology is featured in an article in the December 2014 issue of Nature Biotechnology . Entitled " Listeria vaccines join the checkpoint frenzy," the article explores the potential of the Listeria bacterium as a vector to enhance an anti-tumor response given its ability to induce powerful innate and adaptive immune responses.

Tags: featured nature biotechnology immunotherapy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »